Social Sentiment Ticker Powered by AI

DOW/USDDow Jones Industrial Average/USD
36,245.50
0.00
neutral
SPX/USDStandard & Poor’s 500/USD
4,594.63
0.00
neutral
NDX/USDNASDAQ-100/USD
15,997.58
0.00
neutral
AAPL/USDApple Inc./USD
191.32
+0.08(0.04%)
bullish
GOOGL/USDAlphabet Inc. Class A Common Stock/USD
131.93
+0.07(0.05%)
bullish
TSLA/USDTesla, Inc. Common Stock/USD
239.37
+0.54(0.22%)
bullish
META/USDMeta Platforms, Inc. Class A Common Stock/USD
324.82
0.00
neutral
NVDA/USDNvidia Corp/USD
468.12
+0.47(0.10%)
bullish
AMD/USDAdvanced Micro Devices/USD
121.50
+0.11(0.09%)
bullish
COIN/USDCoinbase Global, Inc. Class A Common Stock/USD
134.71
+0.95(0.71%)
bullish
NFLX/USDNetFlix Inc/USD
465.23
-0.51(0.11%)
bearish
BTC/USDBitcoin – United States Dollar/USD
39,526.15
+822.61(2.13%)
bullish
ETH/USDEthereum – United States Dollar/USD
2,168.51
+80.10(3.84%)
bullish
XRP/USDRipple – United States Dollar/USD
0.62
+0.01(1.39%)
bullish
DOGE/USDDogecoin – United States Dollar/USD
0.09
+0.00(3.64%)
bullish

Social Sentiment Ticker Powered by AI

DOW/USDDow Jones Industrial Average/USD
36,245.50
0.00
neutral
SPX/USDStandard & Poor’s 500/USD
4,594.63
0.00
neutral
NDX/USDNASDAQ-100/USD
15,997.58
0.00
neutral
AAPL/USDApple Inc./USD
191.32
+0.08(0.04%)
bullish
GOOGL/USDAlphabet Inc. Class A Common Stock/USD
131.93
+0.07(0.05%)
bullish
TSLA/USDTesla, Inc. Common Stock/USD
239.37
+0.54(0.22%)
bullish
META/USDMeta Platforms, Inc. Class A Common Stock/USD
324.82
0.00
neutral
NVDA/USDNvidia Corp/USD
468.12
+0.47(0.10%)
bullish
AMD/USDAdvanced Micro Devices/USD
121.50
+0.11(0.09%)
bullish
COIN/USDCoinbase Global, Inc. Class A Common Stock/USD
134.71
+0.95(0.71%)
bullish
NFLX/USDNetFlix Inc/USD
465.23
-0.51(0.11%)
bearish
BTC/USDBitcoin – United States Dollar/USD
39,526.15
+822.61(2.13%)
bullish
ETH/USDEthereum – United States Dollar/USD
2,168.51
+80.10(3.84%)
bullish
XRP/USDRipple – United States Dollar/USD
0.62
+0.01(1.39%)
bullish
DOGE/USDDogecoin – United States Dollar/USD
0.09
+0.00(3.64%)
bullish

Download App

For a Limited Time Get 1 Month Free of TradeZing+

For a Limited Time Get 1 Month Free of TradeZing+

Learn More
Back

Live Audio Room

No related audio room.

Related Events

No related events.


Latest Feed

0

December 2, 2023

43 mins ago

# of Events: 0

Bitcoin's Next All Time High, PYTH, ATOM, LINK & MORE!!

Get The Hottest Crypto Deals https://www.coinbureau.com/deals/ ♣️ Coin Bureau Club https://hub.coinbureau.com/ …

0

107959

YouTube

0

December 2, 2023

2 hours ago

# of Events: 0

GM CEO on @tesla’s Cybertruck #shorts

GM CEO Mary Barra breaks down her thoughts on Tesla’s new Cybertruck and details how GM views its competition in relation to …

0

107956

YouTube


Related to Reddit


Related to X


Related to YouTube

7

Silo Pharma Enters into Exclusive License Agreement with Medspray Pharma BV for Intranasal Technology used in SPC-15 Treatment for PTSD

November 21, 2023

2 weeks ago

MedSpray’s patented nose-to-brain intranasal technology selected for SPC-15 drug delivery

Continue Reading

Feed Topics

News

Feed Tags

Share this Feed News

Subscribe
Notify of

5 Comments
Oldest

Newest
Most Voted

Inline Feedbacks
View all comments

rocio piqueras
rocio piqueras


11 days ago

 MedSpray’s patented nose-to-brain delivery tech taking center stage! 🔍 What’s your take on this development? How might it impact Silo Pharma’s trajectory in the medical field? 

Pilar
Pilar


11 days ago

Now that’s what I call a nasal breakthrough! 

ameliarobbin
ameliarobbin


11 days ago

🌬️ Nasal drug delivery for PTSD? Silo Pharma’s deal with Medspray Pharma seems like a bold and interesting step. Can’t wait to see how this innovative approach unfolds in the world of pharmaceuticals! 🤔💡

john1307
john1307


11 days ago

Intriguing collaboration! Silo Pharma’s move to partner with Medspray Pharma for the patented intranasal technology in SPC-15 shows a commitment to advancing PTSD treatment methods. 🤝🌐

liamport
liamport


11 days ago

🚀 Exciting news! Silo Pharma’s exclusive license agreement with Medspray Pharma for the intranasal technology in SPC-15 is a game-changer for PTSD treatment. 👃💊 Kudos to innovation in drug delivery!

Copied